Pharmacognosy intro
Cananga odorata (Lam.) Hook.f. & Thomson (Annonaceae), known as Ylang Ylang or "flower of flowers," yields essential oil from fresh flowers via sequential steam distillation into graded fractions (Extra Super through Third). The phytochemical profile includes linalool (2-30% depending on fraction), benzyl benzoate (5-15%), benzyl alcohol (1-8%), germacrene D (approximately 30% of the hydrocarbon fraction), and beta-caryophyllene (approximately 33% of the hydrocarbon fraction). Linalool acts as an anxiolytic monoterpenol that inhibits voltage-gated sodium channels, reducing neuronal excitability, and modulates serotonergic signaling via 5-HT1A receptors. Notably, it does not act through the classical benzodiazepine binding site on GABA-A receptors but interacts with the channel pore. Beta-caryophyllene is a selective CB2 cannabinoid receptor agonist (Ki approximately 155 nM), producing anti-inflammatory and anxiolytic effects without psychoactive CB1 activation. Benzyl benzoate contributes CNS depressant properties to the overall sedative profile. In an RCT (n=40), transdermal ylang ylang application produced significant decreases in systolic and diastolic blood pressure with increased skin temperature and self-reported calmness (Hongratanaworakit & Buchbauer, 2006). A study of 15 healthy men showed that 60-minute fragrance exposure significantly reduced heart rate and blood pressure (Jung et al., 2013). In 144 participants, ylang ylang significantly decreased alertness while increasing calmness, with reduced P300 amplitude suggesting decreased information processing resource allocation (Moss et al., 2008). Significant alpha brain wave enhancement was measured in 20 subjects after inhalation (Ishiguchi et al., 2008). One of the most pharmacologically distinctive findings is ylang ylang's ability to uncouple physiological and behavioral arousal. It reduces autonomic stress markers, including heart rate and blood pressure, without necessarily causing drowsiness (Hongratanaworakit & Buchbauer, 2004). This parasympathetic activation without cognitive sedation distinguishes it from classical sedative agents.